Rosenberg Noah L.
- SEC CIK
- 0001579649
In the past year, 2 open-market purchase filings worth $40.6K and no sales.
Current role at each company
- VRCA Verrica Pharmaceuticals Inc.CMOas of Aug 18, 2026
- TVTX Travere Therapeutics, Inc.Chief Medical Officeras of Aug 17, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $40.6K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$40.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rosenberg Noah L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRCA Verrica Pharmaceuticals Inc.
CMO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rosenberg Noah L.CMO | PPurchase | +2.36K | $4.24 | +$9.99K | New position2.36K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Rosenberg Noah L.CMO | PPurchase | +589 | – | – | –589 after | Derivative |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 17-18 | 1 day | Rosenberg Noah L.CMO | PPurchase | +6.23K | $4.91 | +$30.6K | +264.3%8.59K after | 2 lots |
TVTX Travere Therapeutics, Inc.
Chief Medical Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 (view filing) | Jul 28 | 1 day | Rosenberg Noah L.Chief Medical Officer | SSale | −1.25K | $13.81 | −$17.3K | −2.7%44.5K after | |
| Aug 17, 2021 (view filing) | Aug 17 | Same day | Rosenberg Noah L.Chief Medical Officer | SSale | −1.41K | $17.12 | −$24.1K | −2.9%47.6K after |